Scanmed S.A.

Clinical trials at this site focus on cardiovascular diseases, with research centered on acute coronary syndrome, established cardiovascular disease, high cardiovascular risk, and hypertension. The studies aim to better understand treatment options and assess whether new approaches can improve outcomes for patients with serious heart and vascular conditions.

• Evaluating whether metformin can help reduce unplanned coronary revascularization after percutaneous coronary angioplasty in patients with acute coronary syndrome.
• Testing a new treatment approach for hypertension in people with established cardiovascular disease or elevated cardiovascular risk.
• Measuring the impact of investigational therapies on major events such as cardiovascular death, myocardial infarction, stroke, and heart failure events.

The research activity at Scanmed S.A. reflects a strong interest in improving prevention and treatment strategies for patients with complex cardiovascular conditions, especially those at risk of recurrent events.